Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L Carter

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Seminars in Neurology|January 15, 2004
Practical consultations: multiple sclerosisDean M Wingerchuk, Jonathan L Carter
Expert Opinion on Pharmacotherapy|June 17, 2020
An evaluation of dimethyl fumarate for the treatment of relapsing remitting multiple sclerosisCristina Valencia-Sanchez, Jonathan L Carter
Biologics : Targets & Therapy|July 8, 2021
Using Monoclonal Antibody Therapies for Multiple Sclerosis: A ReviewPaul M Elsbernd, Jonathan L Carter
Mayo Clinic Proceedings|February 4, 2014
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategiesDean M Wingerchuk, Jonathan L Carter
Multiple Sclerosis and Related Disorders|April 17, 2015
Positive neurologic phenomena with initiation of dalfampridine for multiple sclerosisGreg M Thaera, Dean M Wingerchuk, Jonathan L Carter
Frontiers in Physiology|March 12, 2026
Hutchinson-Gilford progeria syndrome alters the endothelial genetic response to laminar shear stressCrystal C Kennedy, Jonathan L Carter, George A Truskey
Multiple Sclerosis and Related Disorders|December 28, 2020
Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and reviewPaul M Elsbernd, William R Hoffman, Jonathan L Carter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 19, 2019
The spectrum of acute cardiopulmonary events associated with multiple sclerosis exacerbationsCristina Valencia-Sanchez, Brent P Goodman, Jonathan L Carter, et al.
Journal of the American Pharmacists Association : Japha|May 11, 2010
Health care reform legislation: momentous implications for shaping pharmacy's futureCynthia J Boyle, Raymond C Love, Leticia R Moczygemba, et al.
The Neurologist|May 7, 2010
Are corticosteroids efficacious for preventing or treating neutralizing antibodies in multiple sclerosis patients treated with beta-interferons? A critically appraised topicSrijana Zarkou, Jonathan L Carter, Kay E Wellik, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Seminars in Neurology|January 15, 2004
Practical consultations: multiple sclerosisDean M Wingerchuk, Jonathan L Carter
Expert Opinion on Pharmacotherapy|June 17, 2020
An evaluation of dimethyl fumarate for the treatment of relapsing remitting multiple sclerosisCristina Valencia-Sanchez, Jonathan L Carter
Biologics : Targets & Therapy|July 8, 2021
Using Monoclonal Antibody Therapies for Multiple Sclerosis: A ReviewPaul M Elsbernd, Jonathan L Carter
Mayo Clinic Proceedings|February 4, 2014
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategiesDean M Wingerchuk, Jonathan L Carter
Multiple Sclerosis and Related Disorders|April 17, 2015
Positive neurologic phenomena with initiation of dalfampridine for multiple sclerosisGreg M Thaera, Dean M Wingerchuk, Jonathan L Carter
Frontiers in Physiology|March 12, 2026
Hutchinson-Gilford progeria syndrome alters the endothelial genetic response to laminar shear stressCrystal C Kennedy, Jonathan L Carter, George A Truskey
Multiple Sclerosis and Related Disorders|December 28, 2020
Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and reviewPaul M Elsbernd, William R Hoffman, Jonathan L Carter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 19, 2019
The spectrum of acute cardiopulmonary events associated with multiple sclerosis exacerbationsCristina Valencia-Sanchez, Brent P Goodman, Jonathan L Carter, et al.
Journal of the American Pharmacists Association : Japha|May 11, 2010
Health care reform legislation: momentous implications for shaping pharmacy's futureCynthia J Boyle, Raymond C Love, Leticia R Moczygemba, et al.
The Neurologist|May 7, 2010
Are corticosteroids efficacious for preventing or treating neutralizing antibodies in multiple sclerosis patients treated with beta-interferons? A critically appraised topicSrijana Zarkou, Jonathan L Carter, Kay E Wellik, et al.
Pageof 2